Literature DB >> 9277

Glutathione reductase from human erythrocytes. Catalytic properties and aggregation.

D J Worthington, M A Rosemeyer.   

Abstract

The catalytic properties of glutathione reductase from human erythrocytes have been studied over a range of buffer conditions and substrate concentrations. This study provides optimal conditions for determining the basic kinetic parameters of the enzyme. The catalytic behaviour of glutathione reductase is consistent with spatially separated binding sites for its substrates. In certain assays anomalies were observed which are correlated with an inactivation of the enzyme by NADPH. Concurrent sedimentation experiments showed that NADPH promoted aggregation of the enzyme. Both inactivation and aggregation could be connected with oxidation of thiols at the active site. The relation of the properties of glutathione reductase to cellular conditions is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 9277     DOI: 10.1111/j.1432-1033.1976.tb10654.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  27 in total

1.  A biophysically based mathematical model for the catalytic mechanism of glutathione reductase.

Authors:  Venkat R Pannala; Jason N Bazil; Amadou K S Camara; Ranjan K Dash
Journal:  Free Radic Biol Med       Date:  2013-10-09       Impact factor: 7.376

2.  Properties and physiological function of a glutathione reductase purified from spinach leaves by affinity chromatography.

Authors:  B Halliwell; C H Foyer
Journal:  Planta       Date:  1978-01       Impact factor: 4.116

3.  Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells.

Authors:  Mourad Ferdaoussi; Xiaoqing Dai; Mette V Jensen; Runsheng Wang; Brett S Peterson; Chao Huang; Olga Ilkayeva; Nancy Smith; Nathanael Miller; Catherine Hajmrle; Aliya F Spigelman; Robert C Wright; Gregory Plummer; Kunimasa Suzuki; James P Mackay; Martijn van de Bunt; Anna L Gloyn; Terence E Ryan; Lisa D Norquay; M Julia Brosnan; Jeff K Trimmer; Timothy P Rolph; Richard G Kibbey; Jocelyn E Manning Fox; William F Colmers; Orian S Shirihai; P Darrell Neufer; Edward T H Yeh; Christopher B Newgard; Patrick E MacDonald
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

4.  Redox interconversion of glutathione reductase from Escherichia coli. A study with pure enzyme and cell-free extracts.

Authors:  A M Mata; M C Pinto; J López-Barea
Journal:  Mol Cell Biochem       Date:  1985-05       Impact factor: 3.396

5.  Purification and characterization of glutathione reductase (E.C. 1.8.1.7) from bovine filarial worms Setaria cervi.

Authors:  Kavita Arora; Rumana Ahmad; Arvind K Srivastava
Journal:  J Parasit Dis       Date:  2012-07-18

6.  Purification and properties of glutathione reductase from liver of the anoxia-tolerant turtle, Trachemys scripta elegans.

Authors:  William G Willmore; Kenneth B Storey
Journal:  Mol Cell Biochem       Date:  2006-10-31       Impact factor: 3.396

7.  Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.

Authors:  Svenja Meierjohann; Rolf D Walter; Sylke Müller
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

8.  Relating mutant genotype to phenotype via quantitative behavior of the NADPH redox cycle in human erythrocytes.

Authors:  Pedro M B M Coelho; Armindo Salvador; Michael A Savageau
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

9.  Engineering the substrate specificity of glutathione reductase toward that of trypanothione reduction.

Authors:  G B Henderson; N J Murgolo; J Kuriyan; K Osapay; D Kominos; A Berry; N S Scrutton; N W Hinchliffe; R N Perham; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

10.  Quantifying global tolerance of biochemical systems: design implications for moiety-transfer cycles.

Authors:  Pedro M B M Coelho; Armindo Salvador; Michael A Savageau
Journal:  PLoS Comput Biol       Date:  2009-03-20       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.